Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 3


Figure 3 Kaplan-Meier Survival Distributions Without MACE Based on the Presence or Absence of Abnormal Wall Motion With Dipyridamole

(Top) Unadjusted curves; (bottom) survival curves adjusted for diabetes, hypertension, and previous infarction; (left) whole group; (right) nonrevascularized patients. Dashed lines = presence (≥1 segment) of abnormal wall motion with dipyridamole; solid lines = absence (0 to 1 segment) of abnormal wall motion with dipyridamole. AWM-D = number of segments with abnormal wall motion with dipyridamole; MACE = major adverse cardiac events.